# Effect of Piroxicam on Ovulation

> **NCT01320709** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 72 (actual)

## Conditions studied

- Contraception, Postcoital

## Interventions

- **DRUG:** Piroxicam ( BAYl1902)
- **DRUG:** Piroxicam ( BAYl1902)
- **DRUG:** Placebo
- **DRUG:** Piroxicam ( BAYl1902)

## Key facts

- **NCT ID:** NCT01320709
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2012-03
- **Final completion:** 2012-05
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2015-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01320709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01320709, "Effect of Piroxicam on Ovulation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01320709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*